APPLYING PULSED ELECTRIC FIELDS IN THE TREATMENT OF NEURAL DISORDERS
Damaged, diseased, abnormal, obstructive, cancerous or undesired neural tissue treated by delivering specialized pulsed electric field (PEF) energy to target tissue areas. In some instances, the target tissue includes a tumor, a benign tumor, a malignant tumor, a cyst, or an area of diseased tissue. Most brain and spinal cord tumors develop from glial cells. These tumors are sometimes referred to as a group called gliomas. They arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). One difficulty in the treatment of gliomas is that they are behind the blood-brain barrier (BBB) and blood-tumor barrier (BTB) which leads to poor delivery of anti-cancer drugs or immune agents to the tumor-infiltrated brain. Devices, systems and methods are provided that treat the tumor directly, such as by ablation, and optionally transiently disrupt the BBB coupled with adjuvant antibody, biologic, or other pharmaceutical interventions.
1 . A method of treating a portion of neural tissue comprising:
positioning a delivery electrode near the portion of the neural tissue; and
delivering pulsed electric field energy through the electrode to the neural tissue so that that the energy non-thermally treats the portion of the neural tissue creating a lesion while maintaining non-cellular elements within the lesion.
2 . A method as in claim 1 , wherein the pulsed electric field energy stuns at least one cell within the portion of the tissue.
3 . A method as in claim 2 , wherein at least one cell is stunned in a manner that causes cell death of the at least one cell at a later time.
4 . A method as in claim 1 , further comprising delivering a fluid agent to the portion of neural tissue.
5 . A method as in claim 4 , wherein delivering the fluid agent comprises passing the fluid agent through the delivery electrode.
6 . A method as in claim 4 , wherein the fluid agent comprises a chemotherapeutic agent.
7 . A method as in claim 6 , wherein at least one cell within the portion of tissue undergoes cell death caused by uptake of the chemotherapeutic agent.
8 . A method as in claim 4 , wherein the fluid agent comprises genetic material.
9 . A method as in claim 8 , wherein the pulsed electric field energy causes transfection of at least one cell of the tissue with the genetic material.
10 . A method as in claim 9 , wherein the transfection treats Alzheimer's disease or Parkinson's disease.
11 . A method as in claim 4 , wherein the fluid agent comprises an immunostimulant.
12 . A method as in claim 11 , wherein the immunostimulant encourages expression of proteins that promote immune infiltration, activation or conversion.
13 . A method as in claim 1 , wherein the neural tissue comprises brain tissue and/or neuroglia.
14 . A method as in claim 13 , wherein the pulsed electric field energy is configured to transiently disrupt a blood brain barrier.
15 . A method as in claim 14 , further comprising delivering a fluid agent so as to pass through the disrupted blood brain barrier to the portion of neural tissue.
16 . A method as in claim 1 , further comprising positioning a remote return electrode so that the delivery electrode delivers energy in a monopolar manner.
17 . A method as in claim 1 , wherein the delivery electrode has a needle shape and wherein positioning the delivery electrode comprises penetrating the portion of tissue with the delivery electrode.
18 . A method as in claim 1 , wherein positioning the delivery electrode comprises positioning the delivery electrode within a lumen near the portion of tissue so that the pulsed electric field energy passes through a wall of the lumen to the portion of tissue.
19 . A method of treating a portion of tissue with a brain comprising:
positioning a delivery electrode near the portion of the tissue;
delivering a fluid agent through a cerebrovascular system near the portion of the tissue; and
delivering pulsed electric field energy through the electrode so as to transiently disrupt a blood brain barrier near the portion of tissue allowing the fluid agent to pass through the blood brain barrier to the portion of tissue.
20 . A method as in claim 19 , wherein the pulsed electric field energy destroys cells within the portion of the tissue creating a lesion while maintaining non-cellular elements within the lesion.
21 . A method as in claim 19 , wherein the pulsed electric field energy stuns cells within the portion of the tissue causing cell death at a later time.
22 . A method as in claim 21 , wherein the pulsed electric field energy causes cell death at a later time due to a combination of the pulsed electric field energy and by uptake of the fluid agent.